Article Details

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ...

Retrieved on: 2025-04-15 21:46:25

Tags for this article:

Click the tags to see associated articles and topics

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation .... View article details on hiswai:

Excerpt

RB-164™ is a next generation ROR-1 ADC which employs an Fc-silenced monoclonal antibody, glutamine side chain-based conjugation to prevent ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo